[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
Lamers
C B
CB
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000188:drug therapy; D005744:Gastric Acid / Q000378:metabolism; D017506:H(+)-K(+)-Exchanging ATPase; D006801:Humans; D066298:In Vitro Techniques; D009853:Omeprazole; D010295:Parietal Cells, Gastric / Q000187:drug effects* / Q000502:physiology
D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D000251:Adenosine Triphosphatases; D017506:H(+)-K(+)-Exchanging ATPase; D009853:Omeprazole
Remming van H+/K+-ATPase in de pariëtale cel door omeprazol: een nieuw principe van maagzuurremming.